Outset Medical financials
$3.03+2.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.6M | $27.9M | $28.9M | $29.4M | $31.4M | $29.8M | $29.5M | $28.7M | $27.4M | $28.2M | $30.5M | $30.4M |
| Gross profit | $13.3M | $12.1M | $12.2M | $11.6M | $11.9M | $11.1M | $10.7M | $9.8M | $9.8M | $8.2M | $7.7M | $7.2M |
| Gross margin | 42.0% | 43.4% | 42.4% | 39.4% | 37.8% | 37.2% | 36.5% | 34.3% | 35.7% | 29.2% | 25.3% | 23.6% |
| Operating income | -$15.7M | -$16.9M | -$17.6M | -$15.8M | -$16.9M | -$16.4M | -$21.9M | -$23.8M | -$30.8M | -$36.9M | -$37.4M | -$45.5M |
| Net income | -$18.0M | -$19.0M | -$19.5M | -$17.8M | -$18.5M | -$25.8M | -$25.6M | -$27.9M | -$34.5M | -$39.9M | -$38.6M | -$46.2M |
| Net margin | −56.8% | −68.1% | −67.5% | −60.6% | −59.0% | −86.7% | −87.0% | −97.5% | −125.8% | −141.8% | −126.5% | −152.1% |
| Diluted EPS | $-0.97 | $-1.03 | $-1.07 | $-1.00 | $-1.04 | $-3.66 | $-7.29 | $-8.02 | $-9.96 | $-11.77 | $-11.42 | $-13.95 |
| EBITDA | -$15.0M | -$16.1M | -$16.7M | -$14.8M | -$15.7M | -$15.1M | -$20.5M | -$22.4M | -$29.3M | -$35.5M | -$35.9M | -$44.0M |
| Operating cash flow | -$9.6M | -$12.8M | -$9.5M | -$6.3M | -$4.8M | -$25.7M | -$16.5M | -$20.6M | -$33.3M | -$45.9M | -$24.4M | -$34.0M |
| Free cash flow | -$9.7M | -$12.9M | -$9.7M | -$6.5M | -$5.1M | -$25.8M | -$16.5M | -$21.0M | -$33.5M | -$46.3M | -$25.5M | -$34.8M |
| Diluted shares | 18.6M | 18.4M | 18.3M | 17.8M | 17.7M | 7.0M | 3.5M | 3.5M | 3.5M | 3.4M | 3.4M | 3.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.0M | $30.6M | $35.0M | $36.4M | $39.6M | $75.9M |
| Short-term investments | $112.2M | $126.1M | $133.9M | $142.2M | $144.5M | $113.1M |
| Total debt | $99.4M | $97.0M | $96.2M | $95.5M | $94.8M | $94.1M |
| Total assets | $242.4M | $249.5M | $264.5M | $277.3M | $288.8M | $301.2M |
| Total liabilities | $146.0M | $137.8M | $137.5M | $134.9M | $134.0M | $131.3M |
| Shareholders' equity | $96.3M | $111.7M | $127.0M | $142.4M | $154.8M | $169.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology